Fact CheckerSign in

NCT06728514CompletedPhase 2/3

Comparative Study of USG Guided ESPB vs USG Guided PVB For Post-op Analgesia In Patient's After Open Renal Surgeries

Comparative Study of Ultrasound Guided Erector Spinae Plane Block vs Ultrasound Guided Paravertebral Block For Post-oprative Analgesia In Patient's After Open Renal Surgeries

Source: ClinicalTrials.gov · Last updated 4 May 2026

Brief summary (registry, in English)

Pain control following open renal surgeries are of utmost importance in order to reduce the chance of chronic pain development, and facilitate early rehabilitation. The erector spinae plane block (ESPB) is a recently developed regional anaesthesia procedure successfully used for different types of surgical procedures including open renal surgeries. A Comparative cross-sectional study design will be used and patients fulfilling the inclusion criteria will be included that are admitted through the Outpatient department. Patients will be optimized for surgery. A detailed history will be taken regarding the mode of injury, any preexisting disease and previous surgery and finally thorough examination of the patient will be done to rule out any systemic disease. Informed consent will be taken. These patients will be divided into 2 groups by simple lottery method in group A and B.All the data collected will be entered and analyzed by SPSS version 25.0. Age, surgery d.uration, intraoperative heart rate, intraoperative MAP, total postoperative opioid consumption, total intraoperative opiod and isoflurane consumption, time to first required analgesic, and VAS during the first postoperative 24 h will be summarized, according to normality, into mean (± standard deviation \[SD\]) or median (range). According to data normality, the hypothesis of significant differences between the two studied groups will be challenged using the one-way analysis of variance (with least significant difference correction) or Kruskal-Wallis tests (VAS). Moreover, a p value of \< 0.05 will be regarded to be statistically significant

Status (registry)
Completed
Phase (registry)
Phase 2/3
Study type
Interventional
Enrollment
72 (actual)
First submitted
29 Sept 2024
Start date
11 Jan 2024
Primary completion date
9 Jul 2024
Lead sponsor
Sahiwal medical college sahiwal
NCT number
NCT06728514

What you commit to

  • Study type: Interventional · Phase 2/3
  • Participants enrolled: 72
  • From 11 Jan 2024 to the primary completion date, 9 Jul 2024
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Alcohol or drug abuse.
  • Taking of pain medications within 24 h before surgery.

Other illness

  • Relevant drug allergy.
  • Infection at the site of injection.
  • Chronic hepatic or renal failure.

Other

  • Patients who do not give consent.
  • Pregnancy
  • Deranged coagulation profile

Who the study is looking for

  • Both Genders
  • Age between 18 years to 60 years.
  • BMI ≤ 30 kg/m2
  • ASA I or ASA II

Age in the registry: 18 years to 60 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Sahiwal Medical College,Sahiwal
Coordinator of this site? Confirm its status
SahiwalPakistanUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.